A discovery about the mechanisms that enable the immune system to sustain long-term protection could revolutionize treatment for chronic disease and cancer.

Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...

A groundbreaking £1.65million gene therapy treatment offering hope for sickle cell disease patients has been approved for use ...

Basketball Hall of Famer Dwyane Wade talked for the first time yesterday about his surgery for kidney cancer in December 2023.

Adults are being urged to manage their blood pressure to lower their risk of stroke, as new statistics from the Stroke Association reveal a concerning lack of awareness about its dangers. People with ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

NHS England & Vertex reach deal for sickle cell gene therapy Casgevy, making it available at an undisclosed reduced price ...

Read about exa-cel being rolled out on the NHS, providing a 'functional cure' for some patients with severe sickle cell ...

Questions continue to grow about air safety in the US capital. We hear from Graham Braithwaite, professor of safety and ...

The Heritage Foundation, the conservative think tank behind the controversial policy agenda Project 2025, has referred to HIV ...

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...